Loyola University Medical Center has successfully implanted a newly approved aortic heart valve device in a patient without doing an open-heart surgery, which comes as a major relief to heart patients.
The device called the Medtronic CoreValve System, which has recently been approved by the Food and Drug Administration, is deployed with a catheter which is inserted in an artery in the groin and guided up to the heart to take over the function of a diseased valve.
The procedure is much less invasive than traditional open-heart surgery.
Loyola physicians also implanted the device in patients participating in clinical trials, making the hospital the first Illinois hospital to implement the procedure.
The study was published in the New England Journal of Medicine.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app